Navigation Links
Osteo Science Foundation to Support Scientific and Clinical Research in Oral and Maxillofacial Surgery
Date:10/21/2013

ROSEMONT, Ill., Oct. 21, 2013 /PRNewswire-USNewswire/ -- Dr. Peter Geistlich, chairman of the board of Geistlich Pharma, has established the Osteo Science Foundation to advance hard and soft tissue regeneration in the area of oral, cranial and maxillofacial surgery through high quality basic and clinical research, and education that leads to improved outcomes and quality of life for patients.

(Logo: http://photos.prnewswire.com/prnh/20111219/DC25244LOGO)

Creation of the Osteo Science Foundation was announced at the OMS Faculty Section Business Meeting convened during the 2013 AAOMS Annual Meeting in Orlando, FL, October 7-12. Dr. Jay P. Malmquist, Chairman of the Foundation Board, states that, "Advancements in regenerative medicine are continuously improving clinical outcomes in the area of oral, cranial and maxillofacial surgery. The Osteo Science Foundation seeks to maximize these advancements by supporting scientific and clinical research and education relating to the most effective surgical techniques and clinical use of biomaterials and biologics."

In pursuit of its objective to encourage scientific and clinical research in the area of regenerative medicine, the Osteo Science Foundation has initiated a call for abstracts with a submission deadline of December 1, 2013. The first grants are expected to be awarded in July 2014, with funding of up to $50,000 per project and a maximum duration of two years. Dr. Malmquist noted that there is no proscribed cap on the number of projects that may be accepted for the grants. He further stated that by 2015, the number of grant cycles will be increased to two per year, and the first educational symposium will be held.

"AAOMS is excited to work with the Osteo Science Foundation to encourage research in the area of hard and soft tissue regeneration in the oral, cranio and maxillofacial surgical area," said AAOMS President Dr. Miro A. Pavelka. "Biomaterials and biologics hold tremendous promise for the treatment we provide our patients. This is truly the future of oral and maxillofacial surgery in the United States."

Joining Dr. Malmquist on the Osteo Science Foundation Board are oral and maxillofacial surgeons Dr. Alan S. Herford, chairman and program director of the Department of OMS Residency Program at Loma Linda University School of Dentistry, and Dr. Peter K. Moy, professor, Department of Oral and Maxillofacial Surgery, UCLA School of Dentistry.

Saving Face | Changing Lives® — The American Association of Oral and Maxillofacial Surgeons (AAOMS), the professional organization representing more than 9,000 oral and maxillofacial surgeons in the United States, supports its fellows' and members' ability to practice their specialty through education, research and advocacy. AAOMS fellows and members comply with rigorous continuing education requirements and submit to periodic office anesthesia evaluations.

For further information check the AAOMS Website at www.aaoms.org.


'/>"/>
SOURCE American Association of Oral & Maxillofacial Surgeons
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ampio Pharmaceuticals, Inc. Announces Additional Positive Results for Ampion(TM) in Osteoarthritis of the Knee Clinical Trial
2. Cellular Biomedicine Group Announces Positive Interim Results from Phase I/IIa Clinical Trial for Treatment of Knee Osteoarthritis (KOA)
3. Ampio Pharmaceuticals, Inc. Announces Positive Results for Ampion in Osteoarthritis of the Knee Clinical Trial
4. Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth
5. RNL BIO Co. Ltd. Files IND To Commence Phase II Clinical Trial Of RNL-JointStem For Osteoarthritis In The United States
6. Ampio Pharmaceuticals Completes Enrollment in Run-In SPRING study of Ampion in Osteoarthritis of the Knee
7. Musculoskeletal Network covers the Osteoarthritis Research Society International Conference
8. Nearly 30 Percent of Women Fail to Pick Up New Prescriptions for Osteoporosis, Kaiser Permanente Study Finds
9. Nuovi dati rivelano il crescente problema dellosteoporosi in Europa
10. PharmaPoint: Osteoporosis - US Drug Forecast and Market Analysis to 2022
11. PharmaPoint: Osteoporosis - India Drug Forecast and Market Analysis to 2022
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/13/2017)... June 13, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... announced that the U.S. Food and Drug Administration (FDA) has ... 2015 relating to its Zhejiang, China ... "The successful clearance of the Warning Letter related ... facility is a measure of the progress we have made ...
(Date:6/9/2017)... 2017 AirXpanders, Inc. (ASX: AXP) (AirXpanders or ... manufacture, sale and distribution of the AeroForm® Tissue Expander ... its commercial roll-out in the United States ... one hundred (100) medical institutions and health systems, located ... needle-free alternative for women who choose reconstructive surgery following ...
(Date:6/8/2017)... 2017  StatLab Medical Products ("StatLab" or ... of diagnostic supplies for the anatomic pathology ... Company LP ("Cressey & Company"), a healthcare-focused ... investment in the Company. Cressey & Company ... selling shareholder, Prairie Capital, L.P., with certain ...
Breaking Medicine Technology:
(Date:6/27/2017)... ... June 27, 2017 , ... Building on the success ... became the sixth state to pass legislation which ensures that children can possess ... Louisiana joins the states of Alabama, Arizona, Florida, Utah and Washington who have ...
(Date:6/27/2017)... Illinois (PRWEB) , ... June 27, 2017 , ... Two ... were featured in a video designed to encourage lawmakers to protect Medicaid ... National Center for Assisted Living (AHCA/NCAL), highlights the story of Chuck and Cathy Schwarz, ...
(Date:6/27/2017)... (PRWEB) , ... June 27, 2017 , ... ... today announced the expansion of Atmosera Managed Azure Services . The trusted, ... enhancements in support of the company’s growing customer base. Atmosera’s next generation services ...
(Date:6/27/2017)... Rosemont, Ill. (PRWEB) , ... June 27, 2017 , ... ... & Conditioning Association (NBSCA) have named Javair Gillett of the Houston Rockets the NBSCA ... recipient of the award is decided by NBSCA members who vote to select the ...
(Date:6/27/2017)... ... June 27, 2017 , ... East Los Angeles dentist, Ramin Assili DDS ... experiences. What happens to a woman during pregnancy can have profound effects on a ... a toll on a baby’s long-term health. This study, which was performed at the ...
Breaking Medicine News(10 mins):